Topic
Muscle Invasive Bladder Cancer (MIBC)
8 Podcasts on BackTable
Hear how experienced physicians manage Muscle Invasive Bladder Cancer (MIBC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 67 • 18 Jun 2026
Bladder Cancer Risk Stratification: Best Practices
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes.
This podcast is supported by an educational grant from Johnson & Johnson.
More on Muscle Invasive Bladder Cancer (MIBC)
Loading recent podcasts…
Tumor Board # 67
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
30+ listens
Industry # 101
Jun 9, 2026
with Dr. Ruchika Talwar, Anish Parikh
Are academic medical conferences falling short when it comes to preparing clinicians for the unpredictable realities of...
170+ listens
Urology # 287
Jan 30, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,400+ listens
Urology # 280
Dec 16, 2025
with Dr. Carissa Chu, Dr. Ruchika Talwar
Can genomic classifiers close the gap between what we see and what a tumor will do? In this episode of BackTable...
1,200+ listens
Urology # 310
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
780+ listens
Tumor Board # 54
Apr 7, 2026
with Dr. Tyler Stewart, Dr. Jun Gong
Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...
220+ listens
Tumor Board # 45
Jan 27, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
240+ listens
Urology # 277
Nov 28, 2025
with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam
One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder...
1,100+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.